BeyondSpring (BYSI) Change in Acquisitions & Divestments (2024 - 2026)
BeyondSpring (BYSI) posted Change in Acquisitions & Divestments of $11.6 million for Q1 2026, up 354.51% sequentially from $2.6 million in Q4 2025, and up 482.0% YoY from $2.0 million in Q1 2025.
BeyondSpring (BYSI) Change in Acquisitions & Divestments (2024 - 2026) Analysis & Trends
BeyondSpring has reported Change in Acquisitions & Divestments for 3 years, with the latest figure at $11.6 million in Q1 2026.
- Quarterly Change in Acquisitions & Divestments rose 482.0% year-over-year to $11.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $28.1 million (up 835.73% YoY) and the FY2025 annual result came in at $18.4 million, up 1743.2% from the prior year.
- Change in Acquisitions & Divestments grew to $11.6 million in Q1 2026 per BYSI's latest filing, from $2.6 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $12.8 million in Q2 2025 and troughed at $1.0 million in Q4 2024.
- A 3-year average of $5.2 million and a median of $2.3 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
- The sharpest annual moves came in 2025 and 2026: Change in Acquisitions & Divestments soared 156.1% in 2025, then soared 482.0% in 2026.
- Over 3 years, Change in Acquisitions & Divestments stood at $1.0 million in 2024, then jumped by 156.1% to $2.6 million in 2025, then surged by 354.51% to $11.6 million in 2026.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $11.6 million, $2.6 million, and $1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | BeyondSpring | 29.85 Mn | 29.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.00 Mn |
| Jun 30, 2026 | 15.00 Mn |
| Mar 31, 2026 | 11.64 Mn |
| Mar 31, 2026 | 11.64 Mn |
| Dec 31, 2025 | 2.56 Mn |
| Dec 31, 2025 | 2.56 Mn |
| Sep 30, 2025 | 1.02 Mn |
| Sep 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 12.85 Mn |
| Jun 30, 2025 | 12.85 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Dec 31, 2024 | 1.00 Mn |